×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ELDN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/27
10:26 am
eldn
Is Eledon Pharmaceuticals (ELDN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
Low
Report
Is Eledon Pharmaceuticals (ELDN) The Hot Biotech Stock Under $5? [Yahoo! Finance]
3/23
08:50 am
eldn
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely [Yahoo! Finance]
3/20
04:01 pm
eldn
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
Medium
Report
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
3/4
06:13 pm
eldn
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference [Yahoo! Finance]
3/4
04:05 pm
eldn
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
Low
Report
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
2/12
06:39 pm
eldn
Kidney Transplant Rejection Market to Observe Growth at a CAGR of 4.9% During the Forecast Period (2024-2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Kidney Transplant Rejection Market to Observe Growth at a CAGR of 4.9% During the Forecast Period (2024-2034) | DelveInsight [Yahoo! Finance]
2/7
10:39 am
eldn
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human [Yahoo! Finance]
Low
Report
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human [Yahoo! Finance]
2/7
10:13 am
eldn
eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney [Yahoo! Finance]
Low
Report
eGenesis Announces Second Patient Successfully Transplanted with Genetically Engineered Porcine Kidney [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:01 pm
eldn
eledon pharmaceuticals, inc.
MISS
Report
-10.5%
eledon pharmaceuticals, inc.
8/19/2024
04:36 pm
eldn
eledon pharmaceuticals, inc.
MISS
Report
2.5%
eledon pharmaceuticals, inc.
5/9/2024
07:30 am
eldn
eledon pharmaceuticals, inc.
BEAT
Report
-1.6%
eledon pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/7
05:00 pm
eldn
Form 8-K Eledon Pharmaceuticals, For: Apr 01
Neutral
Report
Form 8-K Eledon Pharmaceuticals, For: Apr 01
3/20
05:01 pm
eldn
Form 10-K Eledon Pharmaceuticals, For: Dec 31
Low
Report
Form 10-K Eledon Pharmaceuticals, For: Dec 31
3/20
04:05 pm
eldn
Form 8-K Eledon Pharmaceuticals, For: Mar 20
Low
Report
Form 8-K Eledon Pharmaceuticals, For: Mar 20
2/14
05:35 pm
eldn
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SCHEDULE 13G/A Eledon Pharmaceuticals, Filed by: ARMISTICE CAPITAL, LLC
1/13
05:30 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: McBride John S.
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: McBride John S.
1/13
05:30 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Katkin Keith
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Katkin Keith
1/13
05:30 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Hillson Jan
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Hillson Jan
1/13
05:30 pm
eldn
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Perrin Steven
Medium
Report
Form 4 Eledon Pharmaceuticals, For: Jan 10 Filed by: Perrin Steven
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: